Fosphenytoin
- PMID: 32809580
- Bookshelf ID: NBK560745
Fosphenytoin
Excerpt
Fosphenytoin is a medication used to manage seizures (treatment of generalized tonic-clonic status epilepticus, focal [partial] onset seizures, or generalized onset seizures, and for the prevention and treatment of seizures occurring during neurosurgery). It is a water-soluble phenytoin prodrug that can be employed in situations where phenytoin use is not advisable. It is in the hydantoin anticonvulsant class of medications. This activity outlines the indications, action, and contraindications for fosphenytoin as a valuable agent for neurosurgery prophylaxis, short-term oral phenytoin substitute, and treatment for status epilepticus. This activity will highlight the mechanism of action, adverse event profile, off-label use, and monitoring pertinent for healthcare team members in managing patients with seizures and related conditions.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Fischer JH, Patel TV, Fischer PA. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures. Clin Pharmacokinet. 2003;42(1):33-58. - PubMed
-
- Browne TR. Fosphenytoin (Cerebyx). Clin Neuropharmacol. 1997 Feb;20(1):1-12. - PubMed
-
- Luer MS. Fosphenytoin. Neurol Res. 1998 Mar;20(2):178-82. - PubMed
-
- Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, Bare M, Bleck T, Dodson WE, Garrity L, Jagoda A, Lowenstein D, Pellock J, Riviello J, Sloan E, Treiman DM. Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016 Jan-Feb;16(1):48-61. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources